Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Fecal Microbiota Transplantation on Gut Bacterial Bile Acid Metabolism in Humans
Jessica-Miranda Bustamante, Tyson Dawson, Caitlin Loeffler, et al.
Nutrients (2022) Vol. 14, Iss. 24, pp. 5200-5200
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Dietary resistant starch supplementation increases gut luminal deoxycholic acid abundance in mice
Melanie A. Reuter, Madelynn Tucker, Zara Marfori, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases
Yanyan Wang, Huangru Xu, Xiqiao Zhou, et al.
Medical Review (2024) Vol. 4, Iss. 4, pp. 262-283
Open Access | Times Cited: 8
Contribution of the microbiome for better phenotyping of people living with obesity
Agostino Di Ciaula, Leonilde Bonfrate, Mohamad Khalil, et al.
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 5, pp. 839-870
Open Access | Times Cited: 18
Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response
Hao Zhang, Li Fu, Xinwen Leiliang, et al.
Cancer Communications (2024) Vol. 44, Iss. 10, pp. 1130-1167
Open Access | Times Cited: 7
Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma
Yang Song, Harry Cheuk-Hay Lau, Xiang Zhang, et al.
Cancer Biology and Medicine (2023), pp. 1-19
Open Access | Times Cited: 15
Prostate and gut: Any relationship? A narrative review on the available evidence and putative mechanisms
Lorenzo Romano, Luigi Napolitano, Felice Crocetto, et al.
The Prostate (2024)
Closed Access | Times Cited: 5
Synergistic Effects of Probiotics and Lifestyle Interventions on Intestinal Microbiota Composition and Clinical Outcomes in Obese Adults
Glauber Pimentel Florêncio, Analicy Rodrigues Xavier, Ana Catarina de Castro Natal, et al.
Metabolites (2025) Vol. 15, Iss. 2, pp. 70-70
Open Access
Probiotic Bifidobacterium reduces serum TMAO in unstable angina patients via the gut to liver to heart axis
Zhihong Zhou, Lizhe Sun, Wei Zhou, et al.
Liver Research (2025) Vol. 9, Iss. 1, pp. 57-65
Open Access
The Functions of Major Gut Microbiota in Obesity and Type 2 Diabetes
Siman Liu, Zhipeng Tao, Mingyu Qiao, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 167-167
Open Access
Digestive dynamics: Unveiling interplay between the gut microbiota and the liver in macronutrient metabolism and hepatic metabolic health
Mrunmayee Kandalgaonkar, Virender Kumar, Matam Vijay‐Kumar
Physiological Reports (2024) Vol. 12, Iss. 12
Open Access | Times Cited: 4
Bile acids impact the microbiota, host, and C. difficile dynamics providing insight into mechanisms of efficacy of FMTs and microbiota-focused therapeutics
Arthur S. McMillan, Casey M. Theriot
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
BNT162b2 mRNA vaccination affects the gut microbiome composition of patients with follicular lymphoma and chronic lymphocytic leukemia
Annalisa Chiarenza, Gaia Vertillo Aluisio, Nunziatina Laura Parrinello, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Fu brick tea supplementation ameliorates non-alcoholic fatty liver disease and associated endotoxemia via maintaining intestinal homeostasis and remodeling hepatic immune microenvironment
Gaolong Zuo, Meng-Hua Li, Xiaoli Guo, et al.
Food Research International (2025), pp. 116207-116207
Closed Access
Alterations in gut microbiome and metabolite profiling during in vitro fermentation of duckweed (Wolffia globosa) and its extracts by gut bacteria from obese adults
Sirajit Dhamaratana, Pawadee Methacanon, Paiboon Tunsagool, et al.
Future Foods (2025), pp. 100608-100608
Open Access
Trust the gut: Outcomes of gut microbiota transplant in metabolic and cognitive disorders
Maria Angela Guzzardi, Federica La Rosa, Patricia Iozzo
Neuroscience & Biobehavioral Reviews (2023) Vol. 149, pp. 105143-105143
Open Access | Times Cited: 9
Bile acid-gut microbiota imbalance in cholestasis and its long-term effect in mice
Xin Yang, Yuesong Xu, Jiakui Li, et al.
mSystems (2024) Vol. 9, Iss. 7
Open Access | Times Cited: 3
Review on chronic metabolic diseases surrounding bile acids and gut microbiota: What we have explored so far
Zhenzheng Zhu, Yuemiao Xu, Yuwei Xia, et al.
Life Sciences (2023) Vol. 336, pp. 122304-122304
Open Access | Times Cited: 6
The Effect of Fecal Microbiota Transplantation on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis
Azin Pakmehr, Seyed Mohammad Mousavi, Hanieh‐Sadat Ejtahed, et al.
Clinical Therapeutics (2023) Vol. 46, Iss. 2, pp. e87-e100
Closed Access | Times Cited: 6
Gut Microbiota and Liver Regeneration: A Synthesis of Evidence on Structural Changes and Physiological Mechanisms
Yana V. Kiseleva, Т. С. Жарикова, Roman Maslennikov, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 14, Iss. 6, pp. 101455-101455
Closed Access | Times Cited: 1
Modulation of Gut Microbial Biomarkers and Metabolites in Cancer Management by Tea Compounds
Hoi Kit Matthew Leung, Emily Kwun Kwan Lo, Fangfei Zhang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6348-6348
Open Access | Times Cited: 1
Obesity-associated inflammation countered by a Mediterranean diet: the role of gut-derived metabolites
Melanie R. Florkowski, Esther Abiona, Karen M. Frank, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 1
Microbiome and Metabolome Restoration After Administration of Fecal Microbiota, Live-jslm (REBYOTA®) for Preventing Recurrent Clostridioides difficile Infection
Ken Blount, Romeo Papazyan, Nicky Ferdyan, et al.
The Journal of Infectious Diseases (2024)
Open Access | Times Cited: 1
Novel Microbial Engraftment Trajectories Following Microbiota Transplant Therapy in Ulcerative Colitis
Daphne Moutsoglou, Aneesh Syal, Sharon Lopez, et al.
Journal of Crohn s and Colitis (2024) Vol. 19, Iss. 2
Closed Access | Times Cited: 1
The Efficacy of Fecal Microbiota Transplantation in Mouse Models Infected with Clostridioides difficile from the Perspective of Metabolic Profiling: A Systematic Review
Anna Voziki, Olga Deda, Melina Kachrimanidou
Metabolites (2024) Vol. 14, Iss. 12, pp. 677-677
Open Access | Times Cited: 1
Resveratrol amplifies the anti-tumor effect of α-PD-1 by altering the intestinal microbiome and PGD2 content
Baohua Luo, Qingling An, Lei Jin, et al.
Gut Microbes (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top